5th Annual Viral Safety and Viral Clearance Summit - Event Resources

Virtual Event

5th Annual Viral Safety and Viral Clearance Summit - Event Resources logo

COVID-19 Immune Globulin Regulation

Dorothy Scott, MD
Branch Chief for the Laboratory of Plasma Derivatives, Office of Blood Research and Review, US FDA, Center for Biologics Evaluation and Research
Download PDF


SARS-CoV-2 Inactivation by Commonly Available Chemicals on Inanimate Surfaces

Eleonora Widmer, MD, PhD
Senior Director Global Pathogen Safety, CSL Behring
Download PDF


Decontamination of N95 Respirators in a Large Hospital System in the COVID-19 Emergency

Ebru Oral, PhD
Associate Professor of Orthopedic Surgery Harvard Medical School, Associate Director at Harris Orthopedic Lab at Massachusetts General Hospital, Fellow of the National Academy of Inventors


Developing and Implementing Viral Safety Strategies for Cell and Gene Therapy

David Hambly, PhD
President, Advanced Therapy Product Consulting, Inc.
Download PDF


Detection of Replication Competent Viruses in Viral Vector Products

Matthew Pennington, PhD
Scientist 1, Virology Department, Charles River
Download PDF


Testing for Replication Competent Viruses in Retroviral and Lentiviral Vector Products

Kenneth Cornetta, MD
Clinical Professor of Medical and Molecular Genetics, Indiana University School of Medicine Director, National Gene Vector Biorepository, Associate Director, Brown Center for Immunotherapy
Download PDF


Viral Safety in Continuous Manufacturing

Scott Lute, PhD
Biologist/Research Reviewer, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Download PDF


Points to Consider for the Development of a Virus Inactivation Process

Jens-Peter Gregersen, DVM, PhD
Independent Biomedicines Consultant
Download PDF


Confronting Antigenic Diversity with Broad-Strain Vaccines

Christopher Locher, PhD
CEO, Versatope Therapeutics, Inc.
Download PDF


Current Perspectives on NGS for Adventitious Virus Detection

Arifa Khan, PhD
Senior Investigator in the Office of Vaccines Research and Review, U.S. Food and Drug Administration, Center for Biologics Evaluation and Research
Download PDF


Evaluation of RNA Next Generation Sequencing (Transcriptomics Analysis) to Replace In Vivo Tests for Assessing the Viral Safety of Cells

Horst Ruppach, PhD
Scientific and Portfolio Director, Global Biologics Charles River

Mark Eloit, DVM, PhD
Founder & Scientific Advisor, Pathoquest
Download PDF


Biotech Viral Safety: New Opportunities and Current Trends in Viral Clearance and Safety

 Kurt Brorson, PhD
 Vice President, Technical, Parexel
Download PDF

Decontamination of PPE via Vaporized Hydrogen Peroxide and Moist Heat Treatment

Cassidy Collins
Senior Technician, Process Evaluation, Charles River




Exploration of Production Conditions to Achieve High Titer Influenza A

Janalyn Frederick
Senior Technician, Process Evaluation, Charles River

Madison Gaiser
Technician 2, Process Evaluation, Charles River



Gene Therapy Studies (AAV Vector): Viral Clearance Challenges

Amanda Budzilowicz
Senior Technician, Process Evaluation, Charles River



Viral Clearance for Medical Devices (Case Study)

Crystal Reitman
Senior Technician, Process Evaluation, Charles River




Evaluating Effects of Pressure Fluctuations by Constant Flow Method on Viral Clearance

Esha Vyas
Field Applications Manager, Asahi Kasei Bioprocess America, Inc.